2024 Q2 Form 10-K Financial Statement

#000121390024033414 Filed on April 16, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2023 Q4 2023
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $327.7K $328.5K $2.223M
YoY Change -13.92% -75.27% -33.27%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $327.7K $328.5K $2.223M
YoY Change -13.92% -75.27% -33.27%
Operating Profit -$2.223M
YoY Change -33.27%
Interest Expense $258.6K $313.6K $2.169M
YoY Change -48.49% -52.49% 93.43%
% of Operating Profit
Other Income/Expense, Net $258.6K $2.169M
YoY Change -48.49% 93.43%
Pretax Income -$69.02K -$14.94K -$54.32K
YoY Change -156.82% -97.77% -97.54%
Income Tax $26.25K $0.00
% Of Pretax Income
Net Earnings -$95.27K -$14.94K -$54.32K
YoY Change -459.14% -98.12% -97.73%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$0.02 $0.00 -$0.01
COMMON SHARES
Basic Shares Outstanding 4.457M shares 4.457M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2024 Q2 2023 Q4 2023
SHORT-TERM ASSETS
Cash & Short-Term Investments $2.560K $6.760K $6.760K
YoY Change 1119.05% -97.82% -97.82%
Cash & Equivalents $2.564K $6.760K
Short-Term Investments
Other Short-Term Assets $40.50K $830.00 $830.00
YoY Change -38.48% -96.68% -96.68%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $43.06K $7.593K $7.590K
YoY Change -73.93% -97.73% -97.73%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles $5.000M $5.000M
YoY Change 0.0% 0.0%
Long-Term Investments $24.27M $23.77M $23.77M
YoY Change -37.54% -70.16% -70.16%
Other Assets $168.0K $161.5K $161.5K
YoY Change 138.89% -24.27% -24.27%
Total Long-Term Assets $24.44M $23.93M $23.93M
YoY Change -37.22% -70.03% -70.03%
TOTAL ASSETS
Total Short-Term Assets $43.06K $7.593K $7.590K
Total Long-Term Assets $24.44M $23.93M $23.93M
Total Assets $24.48M $23.94M $23.94M
YoY Change -37.38% -70.15% -70.15%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.800M $2.846M $2.846M
YoY Change 5.7% 56.5% 56.5%
Accrued Expenses $186.8K $80.00K $80.00K
YoY Change -32.07% -51.03% -51.03%
Deferred Revenue
YoY Change
Short-Term Debt $3.397M $2.845M $2.845M
YoY Change 66.07% 84.11% 84.11%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $19.70M $6.649M $6.649M
YoY Change 248.51% 69.88% 69.88%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $2.705M $2.705M $2.705M
YoY Change 0.0% 0.0% 0.0%
Total Long-Term Liabilities $2.705M $2.705M $2.705M
YoY Change 0.0% 0.0% 0.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $19.70M $6.649M $6.649M
Total Long-Term Liabilities $2.705M $2.705M $2.705M
Total Liabilities $22.40M $9.353M $9.353M
YoY Change 168.08% 41.32% 41.32%
SHAREHOLDERS EQUITY
Retained Earnings -$9.919M -$9.266M
YoY Change 30.21% 56.0%
Common Stock $228.00 $228.00
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$9.918M -$9.266M $14.58M
YoY Change
Total Liabilities & Shareholders Equity $24.48M $23.94M $23.94M
YoY Change -37.38% -70.15% -70.15%

Cashflow Statement

Concept 2024 Q2 2023 Q4 2023
OPERATING ACTIVITIES
Net Income -$95.27K -$14.94K -$54.32K
YoY Change -459.14% -98.12% -97.73%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$194.6K -$647.2K -$1.347M
YoY Change -99.55% 205.68% 38.01%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $19.17K $16.16M $58.04M
YoY Change -99.95% -3506.34% 1418.54%
Cash From Investing Activities $19.17K $16.16M $58.04M
YoY Change -99.95% -3506.34% -1747.13%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 177.8K -15.65M -$57.05M
YoY Change -52.59% -2125.23% -1592.57%
NET CHANGE
Cash From Operating Activities -194.6K -647.2K -$1.347M
Cash From Investing Activities 19.17K 16.16M $58.04M
Cash From Financing Activities 177.8K -15.65M -$57.05M
Net Change In Cash 2.360K -139.5K -$354.9K
YoY Change -100.84% -260.93% -47.65%
FREE CASH FLOW
Cash From Operating Activities -$194.6K -$647.2K -$1.347M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2023 dei Document Type
DocumentType
10-K
CY2023 dei Document Annual Report
DocumentAnnualReport
true
CY2023 dei Document Period End Date
DocumentPeriodEndDate
2023-12-31
CY2023 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023 dei Document Transition Report
DocumentTransitionReport
false
CY2023 dei Entity File Number
EntityFileNumber
001-41183
CY2023 dei Entity Registrant Name
EntityRegistrantName
Welsbach Technology Metals Acquisition Corp.
CY2023 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2023 dei Entity Address Address Line1
EntityAddressAddressLine1
160 S Craig Place
CY2023 dei Entity Address City Or Town
EntityAddressCityOrTown
Lombard
CY2023 dei Entity Address State Or Province
EntityAddressStateOrProvince
IL
CY2023 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
60148
CY2023 dei City Area Code
CityAreaCode
(217)
CY2023 dei Local Phone Number
LocalPhoneNumber
615-1216
CY2023 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2023 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2023 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023 dei Entity Small Business
EntitySmallBusiness
true
CY2023 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2023 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2023 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2023 dei Entity Shell Company
EntityShellCompany
true
CY2023 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2023Q3 dei Entity Public Float
EntityPublicFloat
23140863 usd
CY2024Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
4456827 shares
CY2023Q4 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2023Q4 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2023Q4 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2023Q4 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2023 dei Auditor Firm
AuditorFirmId
1195
CY2023 dei Auditor Name
AuditorName
UHY LLP
CY2023 dei Auditor Location
AuditorLocation
New York
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6760 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
309881 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
833 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
25000 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
7593 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
334881 usd
CY2023Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
161449 usd
CY2022Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
213182 usd
CY2023Q4 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
23769229 usd
CY2022Q4 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
79645156 usd
CY2023Q4 us-gaap Assets
Assets
23938271 usd
CY2022Q4 us-gaap Assets
Assets
80193219 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2846126 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1818627 usd
CY2023Q4 wtma Franchise Tax Payable Current
FranchiseTaxPayableCurrent
80000 usd
CY2022Q4 wtma Franchise Tax Payable Current
FranchiseTaxPayableCurrent
163384 usd
CY2022Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
180688 usd
CY2023Q4 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
583520 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
6648780 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
3913899 usd
CY2023Q4 wtma Deferred Underwriting Fee Payable Non Current
DeferredUnderwritingFeePayableNonCurrent
2704690 usd
CY2022Q4 wtma Deferred Underwriting Fee Payable Non Current
DeferredUnderwritingFeePayableNonCurrent
2704690 usd
CY2023Q4 us-gaap Liabilities
Liabilities
9353470 usd
CY2022Q4 us-gaap Liabilities
Liabilities
6618589 usd
CY2023Q4 us-gaap Temporary Equity Par Or Stated Value Per Share
TemporaryEquityParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Temporary Equity Par Or Stated Value Per Share
TemporaryEquityParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
2172851 shares
CY2022Q4 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
7727686 shares
CY2023Q4 us-gaap Temporary Equity Redemption Price Per Share
TemporaryEquityRedemptionPricePerShare
10.98
CY2022Q4 us-gaap Temporary Equity Redemption Price Per Share
TemporaryEquityRedemptionPricePerShare
10.29
CY2023Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
23850678 usd
CY2022Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
79514266 usd
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2283976 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2283976 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2283976 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2283976 shares
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
228 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
228 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-9266105 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-5939864 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-9265877 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-5939636 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
23938271 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
80193219 usd
CY2023 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2022981 usd
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3131190 usd
CY2023 wtma Franchise Tax
FranchiseTax
200000 usd
CY2022 wtma Franchise Tax
FranchiseTax
200000 usd
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
-2222981 usd
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-3331190 usd
CY2023 us-gaap Investment Income Interest
InvestmentIncomeInterest
2168659 usd
CY2022 us-gaap Investment Income Interest
InvestmentIncomeInterest
1121159 usd
CY2023 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
2168659 usd
CY2022 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1121159 usd
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-54322 usd
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2210031 usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
180688 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-54322 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-2390719 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-1231823 usd
CY2022 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
45540 usd
CY2022 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
73142 usd
CY2022 us-gaap Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
2435776 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-2390719 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-5939636 usd
CY2023 us-gaap Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
2688399 usd
CY2023 wtma Adjustment To Accumulated Deficit Excise Tax On Redemption Of Common Stock
AdjustmentToAccumulatedDeficitExciseTaxOnRedemptionOfCommonStock
583520 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-54322 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-9265877 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-54322 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-2390719 usd
CY2023 us-gaap Investment Income Interest
InvestmentIncomeInterest
2168659 usd
CY2022 us-gaap Investment Income Interest
InvestmentIncomeInterest
1121159 usd
CY2023 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-24167 usd
CY2022 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-307633 usd
CY2023 us-gaap Increase Decrease In Due To Affiliates
IncreaseDecreaseInDueToAffiliates
88000 usd
CY2022 us-gaap Increase Decrease In Due To Affiliates
IncreaseDecreaseInDueToAffiliates
125990 usd
CY2023 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1027499 usd
CY2022 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1818627 usd
CY2023 wtma Increase Decrease In Franchise Tax Payable
IncreaseDecreaseInFranchiseTaxPayable
-83384 usd
CY2022 wtma Increase Decrease In Franchise Tax Payable
IncreaseDecreaseInFranchiseTaxPayable
102634 usd
CY2023 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-180688 usd
CY2022 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
180688 usd
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1347387 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-976306 usd
CY2023 us-gaap Payments To Acquire Restricted Investments
PaymentsToAcquireRestrictedInvestments
750000 usd
CY2022 us-gaap Payments To Acquire Restricted Investments
PaymentsToAcquireRestrictedInvestments
3822397 usd
CY2023 us-gaap Origination Of Notes Receivable From Related Parties
OriginationOfNotesReceivableFromRelatedParties
124166 usd
CY2023 us-gaap Repayment Of Notes Receivable From Related Parties
RepaymentOfNotesReceivableFromRelatedParties
124166 usd
CY2023 wtma Cash Withdrawn From Trust Account In Connection With Redemption
CashWithdrawnFromTrustAccountInConnectionWithRedemption
58351987 usd
CY2023 wtma Cash Withdrawn From Trust Account To Pay Franchise And Income Taxes
CashWithdrawnFromTrustAccountToPayFranchiseAndIncomeTaxes
442599 usd
CY2022 wtma Cash Withdrawn From Trust Account To Pay Franchise And Income Taxes
CashWithdrawnFromTrustAccountToPayFranchiseAndIncomeTaxes
298414 usd
CY2023 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
58044586 usd
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-3523983 usd
CY2022 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
2276860 usd
CY2022 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
45540 usd
CY2023 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
1299934 usd
CY2022 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
1545537 usd
CY2023 wtma Payment To Redeem Common Stock
PaymentToRedeemCommonStock
58351987 usd
CY2022 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
45541 usd
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-57052053 usd
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
3822396 usd
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-354854 usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-677893 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
523063 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1200956 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
168209 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
523063 usd
CY2023Q4 us-gaap Cash
Cash
6760 usd
CY2022Q4 us-gaap Cash
Cash
309881 usd
CY2023Q4 us-gaap Restricted Cash
RestrictedCash
161449 usd
CY2022Q4 us-gaap Restricted Cash
RestrictedCash
213182 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
168209 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
523063 usd
CY2023 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
188177 usd
CY2023 us-gaap Income Taxes Paid
IncomeTaxesPaid
306155 usd
CY2022 us-gaap Income Taxes Paid
IncomeTaxesPaid
85232 usd
CY2022 wtma Deferred Underwriting Commission Payable
DeferredUnderwritingCommissionPayable
79690 usd
CY2023 wtma Due To Shareholders For Redemption Of Common Stock
DueToShareholdersForRedemptionOfCommonStock
583520 usd
CY2023 wtma Accretion For Redeemable Common Stock To Redemption Value
AccretionForRedeemableCommonStockToRedemptionValue
2688399 usd
CY2022 wtma Accretion For Redeemable Common Stock To Redemption Value
AccretionForRedeemableCommonStockToRedemptionValue
2435776 usd
CY2023 us-gaap Stock Issued During Period Shares Purchase Of Assets
StockIssuedDuringPeriodSharesPurchaseOfAssets
1125000 shares
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Percentage Of Outstanding Stock Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum
0.50 pure
CY2023Q4 us-gaap Share Price
SharePrice
10
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
5000001 usd
CY2023 wtma Common Stock Percentage
CommonStockPercentage
0.20 pure
CY2023Q4 us-gaap Revenue Remaining Performance Obligation Percentage
RevenueRemainingPerformanceObligationPercentage
1 pure
CY2023 wtma Dissolution Expenses
DissolutionExpenses
100000 usd
CY2022Q3 us-gaap Business Combination Consideration Transferred Other1
BusinessCombinationConsiderationTransferredOther1
772769 usd
CY2022Q4 us-gaap Business Combination Consideration Transferred Other1
BusinessCombinationConsiderationTransferredOther1
772769 usd
CY2023Q1 us-gaap Payments For Deposits
PaymentsForDeposits
125000 usd
CY2023Q1 us-gaap Share Price
SharePrice
10
CY2023Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
4097964 shares
CY2023Q1 us-gaap Temporary Equity Redemption Price Per Share
TemporaryEquityRedemptionPricePerShare
10.4
CY2023Q1 us-gaap Temporary Equity Aggregate Amount Of Redemption Requirement
TemporaryEquityAggregateAmountOfRedemptionRequirement
42600000 usd
CY2023Q2 wtma Shares Exercising Price
SharesExercisingPrice
42600000 usd
CY2023Q3 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
1456871 shares
CY2023Q3 us-gaap Temporary Equity Redemption Price Per Share
TemporaryEquityRedemptionPricePerShare
10.79
CY2023Q3 us-gaap Temporary Equity Aggregate Amount Of Redemption Requirement
TemporaryEquityAggregateAmountOfRedemptionRequirement
15700000 usd
CY2022Q3 wtma Percentage Of Excise Tax
PercentageOfExciseTax
0.01 pure
CY2023Q1 wtma Stockholders Redeemed Common Shares
stockholdersRedeemedCommonShares
4097964 shares
CY2023Q3 wtma Stockholders Redeemed Common Shares
stockholdersRedeemedCommonShares
1456871 shares
CY2023Q1 us-gaap Payable Common Stock Redeemed
PayableCommonStockRedeemed
42636600 usd
CY2023Q3 us-gaap Payable Common Stock Redeemed
PayableCommonStockRedeemed
15715387 usd
CY2023Q1 wtma Percentage Of Excise Tax
PercentageOfExciseTax
0.01 pure
CY2023 wtma Percentage Of Excise Tax
PercentageOfExciseTax
0.01 pure
CY2023Q4 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
583520 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6760 usd
CY2023Q4 us-gaap Restricted Cash
RestrictedCash
161449 usd
CY2023Q4 wtma Working Capital Amount
WorkingCapitalAmount
6641187 usd
CY2023 wtma Financial Term
FinancialTerm
P1Y
CY2023 us-gaap Use Of Estimates
UseOfEstimates
<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Use of Estimates</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The preparation of consolidated financial statements in conformity with U.S. GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements. Making estimates requires management to exercise significant judgment. Such estimates may be subject to change as more current information becomes available and accordingly the actual results could differ significantly from those estimates. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the consolidated financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Actual results could differ from those estimates.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"> </p>
CY2023 wtma Cash Withdrawn From Trust Account In Connection With Redemption
CashWithdrawnFromTrustAccountInConnectionWithRedemption
58351987 usd
CY2022 wtma Cash Withdrawn From Trust Account To Pay Franchise And Income Taxes
CashWithdrawnFromTrustAccountToPayFranchiseAndIncomeTaxes
298414 usd
CY2022 wtma Payment Of Franchise Taxes
PaymentOfFranchiseTaxes
85232 usd
CY2022Q4 us-gaap Restricted Cash
RestrictedCash
213182 usd
CY2023Q2 us-gaap Restricted Cash
RestrictedCash
142851 usd
CY2023 wtma Withdrawn Trust Account For Taxes
WithdrawnTrustAccountForTaxes
741013 usd
CY2023 wtma Franchise And Income Taxes
FranchiseAndIncomeTaxes
579564 usd
CY2023Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
161449 usd
CY2022Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
213182 usd
CY2022 wtma Fair Value Of Public Rights At Issuance
FairValueOfPublicRightsAtIssuance
2627413 usd
CY2023 wtma Offering Costs Associated With The Ipo And Overallotment
OfferingCostsAssociatedWithTheIPOAndOverallotment
<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Offering Costs associated with the IPO and over-allotment</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Offering costs consist principally of legal, accounting, underwriting fees and other costs directly related to the IPO. Offering costs of the IPO amounted to $4,663,218, which was charged against additional paid-in capital and common stock subject to redemption upon the completion of the IPO. Subsequently, additional offering cost of $125,228 was incurred with the Over-allotment in January 2022 and was also charged against additional paid-in capital and common stock subject to redemption in January 2022.</p>
CY2023 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Concentration of Credit Risk</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Depository Insurance Corporation limit. As of December 31, 2023, the Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such account.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"> </p>
CY2023 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0 pure
CY2022 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.0818 pure
CY2023 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2023Q1 us-gaap Excess Stock Shares Issued
ExcessStockSharesIssued
4097964 shares
CY2023Q1 wtma Aggregate Redemption Amount
AggregateRedemptionAmount
42600000 usd
CY2023Q3 us-gaap Shares Subject To Mandatory Redemption Settlement Terms Amount
SharesSubjectToMandatoryRedemptionSettlementTermsAmount
1456871 usd
CY2023Q3 wtma Aggregate Redemption Amount
AggregateRedemptionAmount
15700000 usd
CY2022 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
77276860 usd
CY2022 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
4626437 usd
CY2022 us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
9491256 usd
CY2022Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
79514266 usd
CY2023 us-gaap Temporary Equity Other Changes
TemporaryEquityOtherChanges
-58351987 usd
CY2023 us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
2688399 usd
CY2023Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
23850678 usd
CY2023Q4 wtma Number Of Shares Issued Per Unit
NumberOfSharesIssuedPerUnit
1 shares
CY2023Q4 wtma Number Of Shares Right To Receive
NumberOfSharesRightToReceive
1 shares
CY2023Q4 wtma Number Of Shares Issued Per Unit
NumberOfSharesIssuedPerUnit
1 shares
CY2023Q4 wtma Number Of Shares Right To Receive
NumberOfSharesRightToReceive
1 shares
CY2022Q1 wtma Aggregate Purchase Price
AggregatePurchasePrice
45540 usd
CY2023 wtma Limited Exception
LimitedException
0.50 pure
CY2023 wtma Transfer Assign Or Sell Any Shares Or Warrants After Completion Of Initial Business Combination Threshold Trading Days
TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdTradingDays
P20D
CY2023 wtma Transfer Assign Or Sell Any Shares Or Warrants After Completion Of Initial Business Combination Threshold Consecutive Trading Days
TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdConsecutiveTradingDays
P30D
CY2022Q1 us-gaap Sale Of Stock Consideration Received Per Transaction
SaleOfStockConsiderationReceivedPerTransaction
259136 usd
CY2023 us-gaap Professional And Contract Services Expense
ProfessionalAndContractServicesExpense
120000 usd
CY2023 wtma Due To Affiliates
DueToAffiliates
88000 usd
CY2023 us-gaap Sponsor Fees
SponsorFees
6000 usd
CY2023 wtma Accrued Services
AccruedServices
26000 usd
CY2022 us-gaap Professional And Contract Services Expense
ProfessionalAndContractServicesExpense
120000 usd
CY2022 wtma Due To Affiliates
DueToAffiliates
26000 usd
CY2022 wtma Payments To Sponsor
PaymentsToSponsor
120000 usd
CY2023Q3 wtma Working Capital Loans
WorkingCapitalLoans
1500000 usd
CY2023 wtma Balance Outstanding Working Capital Notes
BalanceOutstandingWorkingCapitalNotes
549100 usd
CY2022 wtma Balance Outstanding Working Capital Notes
BalanceOutstandingWorkingCapitalNotes
0 usd
CY2023 wtma Balance Outstanding Promisorry Note
BalanceOutstandingPromisorryNote
2296371 usd
CY2022 wtma Balance Outstanding Promisorry Note
BalanceOutstandingPromisorryNote
1545537 usd
CY2023Q4 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
2845471 usd
CY2022Q4 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
1545537 usd
CY2023Q2 us-gaap Repayment Of Notes Receivable From Related Parties
RepaymentOfNotesReceivableFromRelatedParties
124166 usd
CY2023Q2 us-gaap Repayment Of Notes Receivable From Related Parties
RepaymentOfNotesReceivableFromRelatedParties
25000 usd
CY2023Q3 us-gaap Repayment Of Notes Receivable From Related Parties
RepaymentOfNotesReceivableFromRelatedParties
99166 usd
CY2021Q4 us-gaap Sponsor Fees
SponsorFees
10000 usd
CY2023 us-gaap Related Party Tax Expense Due To Affiliates Current
RelatedPartyTaxExpenseDueToAffiliatesCurrent
120000 usd
CY2022 us-gaap Related Party Tax Expense Due To Affiliates Current
RelatedPartyTaxExpenseDueToAffiliatesCurrent
114000 usd
CY2023Q4 wtma Underwriting Fee Per Unit
UnderwritingFeePerUnit
0.2
CY2023Q4 wtma Sale Of Stock Underwriting Fees
SaleOfStockUnderwritingFees
1545537 usd
CY2023 wtma Additional Underwriting Payable Per Share
AdditionalUnderwritingPayablePerShare
0.35
CY2023Q4 wtma Deferred Underwriting Fee Payable Non Current
DeferredUnderwritingFeePayableNonCurrent
2704690 usd
CY2023Q3 us-gaap Net Shares Reclassified To Mandatorily Redeemable Capital Stock Shares
NetSharesReclassifiedToMandatorilyRedeemableCapitalStockShares
2432185 shares
CY2023Q3 us-gaap Shares Issued
SharesIssued
500000 shares
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
100000 shares
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2283976 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2283976 shares
CY2023Q4 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
2172851 shares
CY2022Q4 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
7727686 shares
CY2023Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
52959 usd
CY2023Q4 us-gaap Deferred Costs And Other Assets
DeferredCostsAndOtherAssets
541988 usd
CY2022Q4 us-gaap Deferred Costs And Other Assets
DeferredCostsAndOtherAssets
383835 usd
CY2023Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
594947 usd
CY2022Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
383835 usd
CY2023Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
594947 usd
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
383835 usd
CY2022 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
180688 usd
CY2023 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-211112 usd
CY2022 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-371080 usd
CY2023 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
211112 usd
CY2022 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
371080 usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
180688 usd
CY2022 us-gaap Federal State And Local Income Tax Expense Benefit Continuing Operations
FederalStateAndLocalIncomeTaxExpenseBenefitContinuingOperations
252186 usd
CY2023 us-gaap Federal State And Local Income Tax Expense Benefit Continuing Operations
FederalStateAndLocalIncomeTaxExpenseBenefitContinuingOperations
0 usd
CY2023 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
211112 usd
CY2022 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
371080 usd
CY2023 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2023 wtma Effective Income Tax Rate Reconciliation Permanent Booktax Difference
EffectiveIncomeTaxRateReconciliationPermanentBooktaxDifference
-1.3608 pure
CY2022 wtma Effective Income Tax Rate Reconciliation Permanent Booktax Difference
EffectiveIncomeTaxRateReconciliationPermanentBooktaxDifference
-0.1239 pure
CY2023 us-gaap Effective Income Tax Rate Reconciliation Prior Year Income Taxes
EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes
5.0371 pure
CY2022 us-gaap Effective Income Tax Rate Reconciliation Prior Year Income Taxes
EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes
0 pure
CY2023 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-3.8863 pure
CY2022 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.1679 pure
CY2023 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0 pure
CY2022 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.0818 pure
CY2023 wtma Cash Withdrawn From Trust Account In Connection With Redemption
CashWithdrawnFromTrustAccountInConnectionWithRedemption
58351987 usd
CY2023 wtma Interest Earned On The Trust Account
InterestEarnedOnTheTrustAccount
1391640 usd
CY2023 wtma Interest Earned On Trust Account To Pay Franchise And Income Taxes
InterestEarnedOnTrustAccountToPayFranchiseAndIncomeTaxes
741013 usd
CY2023Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
161449 usd
CY2023Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
usd
CY2022Q4 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
usd
CY2022 us-gaap Stock Issued During Period Value Share Based Compensation Forfeited
StockIssuedDuringPeriodValueShareBasedCompensationForfeited
usd
CY2022 us-gaap Origination Of Notes Receivable From Related Parties
OriginationOfNotesReceivableFromRelatedParties
usd
CY2022 us-gaap Repayment Of Notes Receivable From Related Parties
RepaymentOfNotesReceivableFromRelatedParties
usd
CY2022 wtma Cash Withdrawn From Trust Account In Connection With Redemption
CashWithdrawnFromTrustAccountInConnectionWithRedemption
usd
CY2023 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
usd
CY2023 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
usd
CY2022 wtma Payment To Redeem Common Stock
PaymentToRedeemCommonStock
usd
CY2023 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
usd
CY2022 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CY2023 wtma Deferred Underwriting Commission Payable
DeferredUnderwritingCommissionPayable
usd
CY2022 wtma Due To Shareholders For Redemption Of Common Stock
DueToShareholdersForRedemptionOfCommonStock
usd
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
usd
CY2023Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
usd
CY2022Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
usd
CY2023 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
usd
CY2023 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
usd
CY2022 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
usd
CY2023 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
usd
CY2022 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2023 dei Amendment Flag
AmendmentFlag
false
CY2023 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2023 dei Entity Central Index Key
EntityCentralIndexKey
0001866226

Files In Submission

Name View Source Status
0001213900-24-033414-index-headers.html Edgar Link pending
0001213900-24-033414-index.html Edgar Link pending
0001213900-24-033414.txt Edgar Link pending
0001213900-24-033414-xbrl.zip Edgar Link pending
ea0203867-10k_welsbachtech.htm Edgar Link pending
ea020386701ex31-1_welsbach.htm Edgar Link pending
ea020386701ex31-2_welsbach.htm Edgar Link pending
ea020386701ex32-1_welsbach.htm Edgar Link pending
ea020386701ex97-1_welsbach.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
ea0203867-10k_welsbachtech_htm.xml Edgar Link completed
Show.js Edgar Link pending
wtma-20231231.xsd Edgar Link pending
wtma-20231231_def.xml Edgar Link unprocessable
wtma-20231231_lab.xml Edgar Link unprocessable
wtma-20231231_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
wtma-20231231_cal.xml Edgar Link unprocessable